Eurofarma Laboratórios S.A. Stock

Stocks

EUFA3

BREUFAACNOR4

Delayed Sao Paulo			5-day change	1st Jan Change
- ^BRL	-.--%		-.--%	-

08-14	Eurofarma Laboratórios S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-15	Eurofarma Laboratórios S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Latest news: Eurofarma Laboratórios S.A.

08-14	Eurofarma Laboratórios S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-15	Eurofarma Laboratórios S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-26	Eurofarma Laboratórios S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
01-23	Bavarian Nordic A/S Signs Distribution Agreement with Eurofarma to Expand Access to Chikungunya Vaccine in Brazil	CI
12-10	Psivant Therapeutics, Inc. announced that it has received $47.5 million in funding from YK Bioventures, Samsara BioCapital LLC, Roivant Sciences Ltd., LSV Capital Management, LLC, Eurofarma Laboratórios S.A. and other investors	CI
11-14	Eurofarma Laboratórios S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
21/10/25	Mentis Care, Inc Appoints Hassan Kotob as Chief Executive Officer	CI
21/10/25	SK Biopharmaceuticals Co., Ltd. Launches Joint Venture with Eurofarma for Ai-Based Epilepsy Management Platform	CI
22/08/25	Eurofarma Laboratórios S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
16/05/25	Eurofarma Laboratórios S.A. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
27/03/25	Eurofarma Laboratórios S.A. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
17/03/25	Eurofarma Laboratórios S.A. acquired 60% stake in Klibra Agenciamento de Marcas e Negócios for approximately BRL 160 million.	CI
15/11/24	Eurofarma Laboratórios S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI

More news

Managers and Directors: Eurofarma Laboratórios S.A.

Manager	Title	Age	Since
Marco Billi CEO	Chief Executive Officer	-	23/11/2021
Alexandre Mendes Palhares IRC	Investor Relations Contact	40	23/11/2021

Director	Title	Age	Since
Maurízio Billi CHM	Chairman	-	23/11/2021
Cristina Presz Palmaka de Luca BRD	Director/Board Member	58	23/11/2021
Juliana Rozenbaum Munemori BRD	Director/Board Member	50	01/01/2019

More insiders

Latest insider transactions

Date	Insider	Type	Quantity	% Market Cap.
1/10/25 A	Controlling Shareholder Brazilian	Buy	1,644,236	0.1665%
12/4/24 A	Controlling Shareholder Brazilian	Sell	15,405,639	1.5600%
12/4/24 A	Controlling Shareholder Brazilian	Buy	15,405,639	1.5600%

Transaction History

Financials

	2024	2025
Net sales	10.97B 2.13B 1.84B 1.74B 1.58B 2.96B 204B 2.98B 20.79B 8.01B 103B 7.99B 7.82B 329B	12.48B 2.42B 2.1B 1.98B 1.8B 3.37B 232B 3.39B 23.64B 9.11B 118B 9.09B 8.89B 374B
Net income	117M 22.75M 19.71M 18.6M 16.88M 31.66M 2.18B 31.89M 222M 85.61M 1.11B 85.44M 83.56M 3.52B	571M 111M 96.05M 90.64M 82.23M 154M 10.62B 155M 1.08B 417M 5.39B 416M 407M 17.13B
Net Debt	-	-

* Estimated data More financial data

Company Profile

Employees

13,000

Sector

More about the company